CAM
DGX icon

Congress Asset Management’s Quest Diagnostics DGX Stock Holding History

Congress Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-20,997
Closed -$1.12M – 241
2013
Q4 		$1.12M Buy
20,997
+3,497
+20% +$207K 0.03% 184
2013
Q3 		$1.08M Buy
17,500
+3,120
+22% +$187K 0.03% 180
2013
Q2 		$872K Buy
+14,380
New +$857K 0.03% 177

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Congress Asset Management's DGX Position: Q1 2014 in Review

Congress Asset Management sold out of Quest Diagnostics (DGX) in Q1 2014, closing a stake of 20,997 shares — an estimated $1.12M sold.

Congress Asset Management first reported a position in DGX in Q2 2013 and held it in 3 quarters. The position peaked at $1.12M in Q4 2013. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • Congress Asset Management reported no remaining Quest Diagnostics position as of Q1 2014 after selling out during the quarter.
  • Congress Asset Management sold 20,997 Quest Diagnostics shares in Q1 2014, an estimated $1.12M.
  • Congress Asset Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 3 quarters.
  • Congress Asset Management's Quest Diagnostics position peaked at $1.12M in Q4 2013.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on Congress Asset Management's 13F filing for Q1 2014, filed 14 May 2014.